Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating steroids and broad-spectrum antibiotics for the treatment of refractory sepsis in Africa. Tuberculosis is listed among …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enhanced Spectrum Antibiotics (broad-spectrum antibiotics)
  • steroids

Snippet

Sponsor: University of Virginia | Conditions: Sepsis, Tuberculosis | Phase 3 | Status: NOT_YET_RECRUITING